Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk
Nutrition, Metabolism & Cardiovascular Diseases, 08/17/2012
Zocchi L et al. – Although metabolic syndrome (MetS) showed some relation with subclinical renal and cardiac damage, it does not predict TOD any better than the risk factors specified in the definitions.
